Month: November 2020

Isoray’s Cesium-131 Spotlighted in Multiple Presentations at ASTRO

Commenting on the presentations, Isoray CEO Lori Woods said, “It is very gratifying that so many Cesium-131 studies made it through review to the meeting proceedings of the world’s leading organization in radiation oncology.

Isoray Announces First Quarter Fiscal 2021 Financial Results

Revenue for the first quarter of fiscal 2021 grew 3% to $2.38 million versus $2.32 million in the prior year comparable period.

Isoray To Announce First Quarter Fiscal 2021 Financial Results on November 10, 2020

To listen to the conference call, please dial (877) 407-8035. For callers outside the U.S., please dial (201) 689-8035.

Scroll to top